Novo Nordisk's chief scientific officer Marcus Schindler ... Syros Pharma, Tessera, Valo, and Vesalius. Paul Biondi, president of Flagship's Pioneering Medicines unit, said the partnership gets ...

Novo Nordisk is planning to open an artificial intelligence ... In September, for example, the company signed an agreement with US start-up Valo Health to apply its AI-powered drug discovery ...

We are excited to share that we have entered into an expanded agreement with Novo Nordisk to discover and develop novel treatments for obesity, type 2 diabetes, and cardiovascular disease based on ...

Photo by News Øresund – Kristoffer Dahl via CC BY 3.0 Novo Nordisk on Wednesday announced an expanded deal with healthtech firm Valo Health to use AI to fuel drug discovery. 2 min read Get More Than ...

Novo Nordisk's U.S.-listed shares are surging 9% Friday morning after the Danish drugmaker reported early stage results for ...

Medicare added Novo Nordisk's Ozempic, Wegovy, and Rybelsus to its 2027 drug price negotiations list. This move could force Novo Nordisk to slash the costs of its top drugs. The company should ...

NEW YORK, NY / ACCESS Newswire / January 24, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about ...

Luxury fashion house LVMH has reclaimed its title as Europe’s most valuable company from Novo Nordisk, as early signs of a luxury comeback coincided with fresh struggles for the Danish Ozempic ...

In a report released today, James Quigley from Goldman Sachs maintained a Buy rating on Novo Nordisk (0QIU – Research Report), with a price target of DKK875.00. The company’s shares closed ...

Few drugs have generated as much excitement as Novo Nordisk's (NYSE: NVO) Ozempic and Wegovy. The U.S. Food and Drug Administration (FDA) approved Ozempic in December 2017 for treating type 2 ...

We recently compiled a list of the 10 Firms Defy Market Pessimism. In this article, we are going to take a look at where Novo ...